http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107970314-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_590aefc0e5ef40e99f0f50ccc212997c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-296
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-238
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-076
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
filingDate 2016-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_012c98a555a04f3ee73d41d84e150548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0840c1f5b6484ccf583c200dae82977
publicationDate 2018-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107970314-A
titleOfInvention A kind of medicine for treating chronic hepatitis and preparation method thereof
abstract The invention discloses a kind of medicine for treating chronic hepatitis and preparation method thereof, the medicine is mainly made by Herba Epimedii, Poria cocos, radix pseudostellariae, the fruit of Chinese wolfberry, radix bupleuri, desmodium, teasel root, windproof, radix astragali and Mesona chinensis Benth.Each raw material has synergistic effect well in prescription, and manufactured medicine can be used for treating chronic hepatitis;Evident in efficacy, treatment cycle is short, and safety is without side-effects.
priorityDate 2016-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62698

Total number of triples: 35.